Literature DB >> 11950906

Eotaxin expression by epithelial cells and plasma cells in chronic asthma.

Rakesh K Kumar1, Paul S Thomas, Da-Qiang Seetoo, Cristan Herbert, Andrew N J McKenzie, Paul S Foster, Andrew R Lloyd.   

Abstract

Chemoattractants such as eotaxin are believed to play an important role in the recruitment of eosinophils into the airways in asthma. We investigated expression of eotaxin in the airway wall in a model of chronic human asthma, in which systemically sensitized mice were exposed to low mass concentrations of aerosolized antigen for 6 weeks. In these animals, the number of intraepithelial eosinophils in the airways was significantly increased 3 hours after exposure and declined by 24 hours. In parallel, immunoreactivity for eotaxin was strikingly up-regulated in airway epithelial cells and in inflammatory cells in the lamina propria. The latter were identified as plasma cells by double immunofluorescent labeling. Increased expression of eotaxin by epithelial cells and plasma cells was also demonstrated in a case of fatal human asthma. In contrast, sensitized mice that received a single exposure to a high mass concentration of aerosolized antigen exhibited delayed eosinophil recruitment, which did not correlate with eotaxin expression. Furthermore, in sensitized chronically exposed interleukin-13-deficient mice there was virtually no recruitment of eosinophils into the airways, although eotaxin expression was greater than or equal to that in wild-type mice. These results indicate that there are striking differences between acute and chronic exposure models in the time course of eotaxin expression and eosinophil recruitment. Although high eotaxin levels alone are not sufficient to cause recruitment of eosinophils into the airways, recurrent exposure may generate or up-regulate additional signals required for eosinophil chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950906     DOI: 10.1038/labinvest.3780442

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Modeling TH 2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma.

Authors:  Paul S Foster; Steven Maltby; Helene F Rosenberg; Hock L Tay; Simon P Hogan; Adam M Collison; Ming Yang; Gerard E Kaiko; Philip M Hansbro; Rakesh K Kumar; Joerg Mattes
Journal:  Immunol Rev       Date:  2017-07       Impact factor: 12.988

2.  Influence of inhaled beclomethasone and montelukast on airway remodeling in mice.

Authors:  Rania R Abdel Aziz; Nadia Y Helaly; Khaled R Zalata; Nariman M Gameil
Journal:  Inflammopharmacology       Date:  2012-02-22       Impact factor: 4.473

Review 3.  Allergic Inflammation: Effect of Propolis and Its Flavonoids.

Authors:  Nada Oršolić
Journal:  Molecules       Date:  2022-10-08       Impact factor: 4.927

4.  Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease.

Authors:  Joerg Mattes; Adam Collison; Maximilian Plank; Simon Phipps; Paul S Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-20       Impact factor: 11.205

5.  Adenovirus vector-mediated YKL-40 shRNA attenuates eosinophil airway inflammation in a murine asthmatic model.

Authors:  Ling Wang; Aihua Bao; Ying Zheng; Aying Ma; Yi Wu; Huanxia Shang; Danruo Fang; Suqin Ben
Journal:  Gene Ther       Date:  2020-10-12       Impact factor: 5.250

6.  Inhibitory effect of dexamethasone on expression of cysteine-rich 61 protein in airway epithelial cells of allergic mouse models.

Authors:  Yong Cao; Hui-Long Chen; Sheng Cheng; Jun-Gang Xie; Wei-Ning Xiong; Yong-Jian Xu; Hui-Juan Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-10-20

7.  Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target.

Authors:  Adam Collison; Cristan Herbert; Jessica S Siegle; Joerg Mattes; Paul S Foster; Rakesh K Kumar
Journal:  BMC Pulm Med       Date:  2011-05-23       Impact factor: 3.317

8.  Interleukin-33 drives activation of alveolar macrophages and airway inflammation in a mouse model of acute exacerbation of chronic asthma.

Authors:  Melissa M Bunting; Alexander M Shadie; Rylie P Flesher; Valentina Nikiforova; Linda Garthwaite; Nicodemus Tedla; Cristan Herbert; Rakesh K Kumar
Journal:  Biomed Res Int       Date:  2013-07-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.